News | January 11, 2024
Aarti Pharmalabs sets up R&D Centre in Navi Mumbai
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
HIFU is a state-of-the-art treatment that utilizes high-frequency sound waves to target and destroy prostate cancer cells
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Arco Lab now holds a 50% stake in Neviton
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
Subscribe To Our Newsletter & Stay Updated
